α2肾上腺素能受体拮抗剂育亨宾并不能促进肥胖受试者体重减轻，但能阻断肾上腺素诱导的血小板聚集。 - Suppr | 超能文献

The alpha-2 adrenoceptor antagonist yohimbine does not facilitate weight loss but blocks adrenaline induced platelet aggregation in obese subjects.

作者信息

Berlin I, Crespo-Laumonnier B, Turpin G, Puech A J

出版信息

Therapie. 1989 Jul-Aug;44(4):301.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

The alpha-2 adrenoceptor antagonist yohimbine does not facilitate weight loss but blocks adrenaline induced platelet aggregation in obese subjects.α2肾上腺素能受体拮抗剂育亨宾并不能促进肥胖受试者体重减轻，但能阻断肾上腺素诱导的血小板聚集。

Therapie. 1989 Jul-Aug;44(4):301.

2

Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.血小板活化因子与肾上腺素在人血小板聚集中的钙依赖性协同相互作用。

Acta Pharmacol Sin. 2003 Jan;24(1):31-6.

3

Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.通过3H-二氢麦角隐亭和3H-育亨宾结合对完整且功能正常的洗涤人血小板的α2-肾上腺素能受体的研究——3H-育亨宾结合与肾上腺素对ADP诱导聚集的增强作用之间的相关性。

Thromb Haemost. 1985 Aug 30;54(2):402-8.

4

The alpha 2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects.α2肾上腺素能受体拮抗剂育亨宾可抑制健康受试者体内肾上腺素诱导的血小板聚集。

Clin Pharmacol Ther. 1991 Apr;49(4):362-9. doi: 10.1038/clpt.1991.42.

5

Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.α-肾上腺素能刺激人血小板中磷脂酰肌醇的合成，作为血小板聚集继发的α-2效应。

J Cell Biochem. 1982;18(2):213-20. doi: 10.1002/jcb.1982.240180208.

6

Staurosporine-independent platelet aggregation induced by the calcium ionophore ionomycin is inhibited by prostacyclin and sodium nitroprusside and stimulated by adrenaline.钙离子载体离子霉素诱导的不依赖于星形孢菌素的血小板聚集受到前列环素和硝普钠的抑制，并受到肾上腺素的刺激。

Arch Biochem Biophys. 1993 Mar;301(2):431-8. doi: 10.1006/abbi.1993.1167.

7

Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.

Eur J Clin Pharmacol. 1990;39(5):447-51. doi: 10.1007/BF00280934.

8

Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.肾上腺素和剪切应力通过一种部分绕过血管性血友病因子-糖蛋白IB相互作用的机制协同诱导血小板聚集。

Biorheology. 1996 May-Jun;33(3):209-29. doi: 10.1016/0006-355X(96)00018-2.

9

Insensitivity to the alpha2-adrenergic receptor blocker yohimbine hydrochloride and occurrence of spontaneous platelet macroaggregation (SPMA) in diabetes.

Platelets. 2005 Mar;16(2):111-5. doi: 10.1080/09537100400005659.

10

Platelet responsiveness to yohimbine hydrochloride and MRS2179 in the context of the interaction between collagen and epinephrine in acute coronary syndrome.在急性冠状动脉综合征中，血小板对盐酸育亨宾和MRS2179在胶原蛋白与肾上腺素相互作用背景下的反应性。

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):105-10. doi: 10.1016/j.bcmd.2009.02.002. Epub 2009 Mar 9.

引用本文的文献

1

Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.育亨宾两种羟基化代谢物的α2-肾上腺素能受体拮抗效能。

Br J Pharmacol. 1993 Apr;108(4):927-32. doi: 10.1111/j.1476-5381.1993.tb13488.x.

2

Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.

Eur J Clin Pharmacol. 1990;39(5):447-51. doi: 10.1007/BF00280934.